eFFECTOR Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
eFFECTOR Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q1 2024.
  • eFFECTOR Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 4.08M shares, a 143% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.19M shares, a 32.8% increase from 2022.
  • eFFECTOR Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.65M shares, a 89.1% decline from 2021.
  • eFFECTOR Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 15.1M shares, a 971% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 4.08M +2.4M +143% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 2.19M +540K +32.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 61.8M +20.6M +50% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 47.8M +6.71M +16.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 1.68M -39.2M -95.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 1.65M -13.5M -89.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 41.2M +24.5M +147% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 41.1M +39.7M +2735% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 40.8M +39.4M +2727% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 15.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 16.7M +15.3M +1061% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 1.45M -13.3M -90.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 1.45M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 1.44M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 14.7M Apr 1, 2020 Jun 30, 2020 8-K 2021-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.